Lisata Therapeutics, Inc. (LSTA) vs Tempest Therapeutics, Inc. (TPST)

Lisata Therapeutics, Inc. and Tempest Therapeutics, Inc. are both Biotechnology companies. Lisata Therapeutics, Inc. and Tempest Therapeutics, Inc. are of similar size ($14.4M and $13.5M). Lisata Therapeutics, Inc. grew revenue faster over the last twelve months: −24.7% against −53.0%. Across the 11 metrics below, Lisata Therapeutics, Inc. leads on 9 and Tempest Therapeutics, Inc. on 2.

Valuation

Metric LSTA TPST Biotechnology median
P/E n/m n/m 7.88
P/S 0.95 39.00 11.47
P/B 1.80 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.28 52.83 10.73
Earnings yield (103.80%) (515.66%) (28.84%)
Free cash flow yield (85.85%) (167.50%) (23.03%)

Profitability

Metric LSTA TPST Biotechnology median
Gross margin 0.49% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (101.66%) (931.14%) (57.72%)
Return on assets (80.81%) (237.25%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSTA TPST Biotechnology median
Revenue growth (TTM) (24.67%) (52.98%) 5.64%
EPS growth (last fiscal year) 20.42% 67.55% —
Revenue growth, 5-year CAGR (20.28%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LSTA TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.69 0.38 4.73
Net debt to EBITDA 0.88 0.29 0.96

Dividend

Metric LSTA TPST Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric LSTA TPST Biotechnology median
Market cap 13.52m 14.39m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack